Mitsui & Co., Ltd., QSimulate, and Quantinuum have announced the launch of a new quantum-integrated chemistry platform named QIDO (Quantum-Integrated Discovery Orchestrator). The platform is designed to reduce the time and cost of developing new drugs and materials through high-precision chemical reaction modeling. This hybrid platform combines classical and quantum computing workflows to accelerate research and development.
QIDO integrates QSimulate’s classical software, QSP Reaction, with Quantinuum’s InQuanto software, which provides an interface to quantum emulators and hardware. This approach is intended to streamline complex quantum-classical workflows for molecular simulations, making quantum chemistry technologies more accessible to industrial settings. The platform’s functions include automatically identifying reaction coordinates and transition states, mapping strongly correlated systems to Hamiltonians, and visualizing quantum circuits and required resources. It provides optimized energy calculations for reactants, products, and transition states using quantum hardware.
The platform’s use cases include catalyst and enzyme design, reaction mechanism elucidation, battery efficiency, and sustainable materials. Mitsui serves as the exclusive distributor of QIDO in Japan. Prior to the general release, Mitsui conducted beta testing with companies including Panasonic Holdings Corporation, JSR Corporation, and Chugai Pharmaceutical. This collaboration is intended to support the application of quantum technology to industrial challenges in the pharmaceutical, energy, and chemical sectors.
Read the full announcement from Quantinuum here and from Mitsui & Co. here.
August 19, 2025
